Table 3.
Univariate and multivariate variables of all-cause mortality 1 year after TAVI
| Univariate analysis | Multivariate analysis | |||
| OR (95% CI) | P value | OR (95% CI) | P value | |
| Age≥85 years (median) | 1.13 (0.58 to 2.28) | 0.73 | ||
| Women | 0.33 (0.17 to 0.64) | <0.01 | 0.31 (0.14 to 0.67) | < 0.01 |
| BMI≤22.2 kg/m2 (median) | 1.05 (0.54 to 2.03) | 0.89 | ||
| Clinical frailty scale≥4 | 3.3 (1.66 to 6.92) | <0.01 | 3.28 (1.47 to 7.3) | < 0.01 |
| STS risk score≥5.9 (median) | 2.09 (1.04 to 4.17) | 0.04 | 1.07 (0.46 to 2.48) | 0.87 |
| Hgb/Cre≤10.1 | 4.78 (2.40 to 9.51) | <0.01 | 2.71 (1.24 to 5.95) | 0.01 |
| Diabetes mellitus | 1.05 (0.48 to 2.29) | 0.9 | ||
| Previous PCI | 1.21 (0.53 to 2.56) | 0.63 | ||
| Atrial fibrillation | 1.23 (0.55 to 2.53) | 0.6 | ||
| Heart failure hospitalisation | 2.72 (1.39 to 5.52) | <0.01 | 2.09 (0.92 to 4.76) | 0.08 |
| Moderate or severe AR | 1.99 (0.91 to 4.09) | 0.08 | 1.13 (0.48 to 2.65) | 0.77 |
| General anaesthesia | 2.24 (1.15 to 4.53) | 0.02 | 2.61 (1.2 to 5.69) | 0.02 |
| Transfemoral approach | 0.72 (0.33 to 1.75) | 0.45 | ||
| Blood transfusion | 1.56 (0.74 to 3.13) | 0.24 | ||
Values are mean±SD deviation or n (%), unless otherwise specified.
AR, aortic valve regurgitation; BMI, body mass index; Cr, creatinine; Hgb, haemoglobin; PCI, percutaneous coronary intervention; STS, Society of Thoracic Surgeons.